Clinical Trial Update: A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province

View source ↗

Summary

A completed clinical trial from the Mario Negri Institute reports a potential founder PKD2 mutation associated with variable phenotypes in Autosomal Dominant Po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Status: COMPLETED